Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study
- PMID: 38484417
- PMCID: PMC10997882
- DOI: 10.1016/j.socscimed.2024.116660
Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study
Abstract
Background: In 2020, 2.8 million people required substance use disorder (SUD) treatment in nonmetropolitan or 'rural' areas in the U.S. Among this population, only 10% received SUD treatment from a specialty facility, and 1 in 500 received medication for opioid use disorder (MOUD). We explored the context surrounding barriers to SUD treatment in the rural United States.
Methods: We conducted semi-structured, in-depth interviews from 2018 to 2019 to assess barriers to SUD treatment among people who use drugs (PWUD) across seven rural U.S. study sites. Using the social-ecological model (SEM), we examined individual, interpersonal, organizational, community, and policy factors contributing to perceived barriers to SUD treatment. We employed deductive and inductive coding and analytical approaches to identify themes. We also calculated descriptive statistics for participant characteristics and salient themes.
Results: Among 304 participants (55% male, mean age 36 years), we identified barriers to SUD treatment in rural areas across SEM levels. At the individual/interpersonal level, relevant themes included: fear of withdrawal, the need to "get things in order" before entering treatment, close-knit communities and limited confidentiality, networks and settings that perpetuated drug use, and stigma. Organizational-level barriers included: strict facility rules, treatment programs managed like corrections facilities, lack of gender-specific treatment programs, and concerns about jeopardizing employment. Community-level barriers included: limited availability of treatment in local rural communities, long distances and limited transportation, waitlists, and a lack of information about treatment options. Policy-level themes included insurance challenges and system-imposed barriers such as arrest and incarceration.
Conclusion: Our findings highlight multi-level barriers to SUD treatment in rural U.S. communities. Salient barriers included the need to travel long distances to treatment, challenges to confidentiality due to small, close-knit communities where people are highly familiar with one another, and high-threshold treatment program practices. Our findings point to the need to facilitate the elimination of treatment barriers at each level of the SEM in rural America.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Competing interests
No conflict declared
Similar articles
-
Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach.Addict Sci Clin Pract. 2018 Dec 3;13(1):23. doi: 10.1186/s13722-018-0124-2. Addict Sci Clin Pract. 2018. PMID: 30509314 Free PMC article.
-
Recent Incarceration, Substance Use, Overdose, and Service Use Among People Who Use Drugs in Rural Communities.JAMA Netw Open. 2023 Nov 1;6(11):e2342222. doi: 10.1001/jamanetworkopen.2023.42222. JAMA Netw Open. 2023. PMID: 37943559 Free PMC article.
-
Substance use and opioid-related stigma among Black communities in the rural South.Arch Psychiatr Nurs. 2023 Oct;46:127-132. doi: 10.1016/j.apnu.2023.09.001. Epub 2023 Sep 10. Arch Psychiatr Nurs. 2023. PMID: 37813495
-
Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review.Subst Abuse Treat Prev Policy. 2022 Aug 26;17(1):62. doi: 10.1186/s13011-022-00463-5. Subst Abuse Treat Prev Policy. 2022. PMID: 36028837 Free PMC article. Review.
-
Barriers and facilitators to accessing inpatient and community substance use treatment and harm reduction services for people who use drugs in the Muslim communities: A systematic narrative review of studies on the experiences of people who receive services and service providers.Drug Alcohol Depend. 2023 Mar 1;244:109790. doi: 10.1016/j.drugalcdep.2023.109790. Epub 2023 Jan 31. Drug Alcohol Depend. 2023. PMID: 36805826 Review.
References
-
- Substance Abuse and Mental Health Services Administration. Results from the 2020 National Survey on Drug Use and Health: Detailed tables. 2022. https://www.samhsa.gov/data/
MeSH terms
Grants and funding
- UG3 DA044831/DA/NIDA NIH HHS/United States
- UG3 DA044825/DA/NIDA NIH HHS/United States
- UH3 DA044822/DA/NIDA NIH HHS/United States
- UH3 DA044798/DA/NIDA NIH HHS/United States
- UG3 DA044798/DA/NIDA NIH HHS/United States
- UH3 DA044826/DA/NIDA NIH HHS/United States
- U24 DA048538/DA/NIDA NIH HHS/United States
- UH3 DA044823/DA/NIDA NIH HHS/United States
- UH3 DA044830/DA/NIDA NIH HHS/United States
- UG3 DA044822/DA/NIDA NIH HHS/United States
- UH3 DA044829/DA/NIDA NIH HHS/United States
- UG3 DA044826/DA/NIDA NIH HHS/United States
- UG3 DA044823/DA/NIDA NIH HHS/United States
- UH3 DA044831/DA/NIDA NIH HHS/United States
- UG3 DA044830/DA/NIDA NIH HHS/United States
- UG3 DA044829/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical